PacBio Files Proxy Materials

Ticker: PACB · Form: DEFA14A · Filed: 2025-05-20T00:00:00.000Z

Sentiment: neutral

Topics: regulatory-filing, proxy-statement

Related Tickers: PACB

TL;DR

PACB filed proxy docs, no fee. Standard procedure.

AI Summary

Pacific Biosciences of California, Inc. (PACB) filed a Definitive Additional Materials (DEFA14A) on May 20, 2025. This filing relates to the company's proxy statement and indicates no fee was required for this filing. The company, headquartered in Menlo Park, CA, operates in the laboratory analytical instruments sector.

Why It Matters

This filing is a routine regulatory submission for Pacific Biosciences, providing shareholders with information related to upcoming corporate actions or meetings, ensuring transparency and compliance.

Risk Assessment

Risk Level: low — This filing is a standard regulatory document (DEFA14A) and does not contain information that inherently increases risk for the company or its investors.

Key Players & Entities

FAQ

What type of filing is this DEFA14A for Pacific Biosciences of California, Inc.?

This filing is a Definitive Additional Materials (DEFA14A) for Pacific Biosciences of California, Inc., filed on May 20, 2025.

What is the Accession Number for this filing?

The Accession Number for this filing is 0001299130-25-000105.

Does Pacific Biosciences of California, Inc. have a fee associated with this filing?

No, the filing indicates that no fee is required for this DEFA14A.

Where is Pacific Biosciences of California, Inc. located?

Pacific Biosciences of California, Inc. is located at 1305 O'Brien Drive, Menlo Park, CA 94025.

What is the Standard Industrial Classification (SIC) code for Pacific Biosciences of California, Inc.?

The SIC code for Pacific Biosciences of California, Inc. is 3826, which corresponds to Laboratory Analytical Instruments.

From the Filing

0001299130-25-000105.txt : 20250520 0001299130-25-000105.hdr.sgml : 20250520 20250520172651 ACCESSION NUMBER: 0001299130-25-000105 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 17 FILED AS OF DATE: 20250520 DATE AS OF CHANGE: 20250520 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PACIFIC BIOSCIENCES OF CALIFORNIA, INC. CENTRAL INDEX KEY: 0001299130 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 161590339 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-34899 FILM NUMBER: 25970107 BUSINESS ADDRESS: STREET 1: 1305 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-521-8000 MAIL ADDRESS: STREET 1: 1305 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER COMPANY: FORMER CONFORMED NAME: PACIFIC BIOSCIENCES OF CALIFORNIA INC DATE OF NAME CHANGE: 20050829 FORMER COMPANY: FORMER CONFORMED NAME: NANOFLUIDICS INC DATE OF NAME CHANGE: 20040729 DEFA14A 1 a2025defa14a-additionalmat.htm DEFA14A Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Statement ☒ Definitive Additional Materials ☐ Soliciting Material Pursuant to §240.14a-12 Pacific Biosciences of California, Inc. (Name of Registrant as Specified In Its Charter) Payment of Filing Fee (Check the appropriate box): ☒ No fee required ☐ Fee paid previously with preliminary materials ☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 GRAPHIC 2 final2024_annualxsharehold.jpg begin 644 final2024_annualxsharehold.jpg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

View on Read The Filing